Increased Production of Functional Recombinant Human Clotting Factor IX by Baby Hamster Kidney Cells Engineered to Overexpress VKORC1, the Vitamin K 2,3-Epoxide-reducing Enzyme of the Vitamin K Cycle
Open Access
- 1 September 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (36) , 31603-31607
- https://doi.org/10.1074/jbc.m505373200
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming CapacityJournal of Biological Chemistry, 2005
- Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseasesJournal of Internal Medicine, 2005
- Warfarin and the Vitamin K-Dependent γ-Carboxylation SystemTrends in Molecular Medicine, 2004
- Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2Nature, 2004
- Identification of the gene for vitamin K epoxide reductaseNature, 2004
- Profactor IX: The propeptide inhibits binding to membrane surfaces and activation by factor XIABiochemistry, 1994
- Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4British Journal of Nutrition, 1994
- Cloning and Expression of the cDNA for Human γ-glutamyl CarboxylaseScience, 1991
- Activation of human factor IX (Christmas factor).Journal of Clinical Investigation, 1978
- IN VITRO METHOD FOR TESTING THE TOXIN‐PRODUCING CAPACITY OF DIPHTHERIA BACTERIAActa Pathologica Microbiologica Scandinavica, 1948